OPEN END TURBO OPTIONSSCHEIN LONG - QUEST DIAGNOSTICS | Real-time BOERSE MUENCHEN 03:09:35 2024-05-23 EDT | ||
| 2.92 EUR | 0.00% |
|
| Current month | +8.55% | ||
| 1 month | +52.08% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
| Date | Price | Change |
|---|---|---|
| 24-05-23 | 2.92 | 0.00% |
| 24-05-22 | 2.92 | -2.01% |
| 24-05-21 | 2.98 | -4.49% |
| 24-05-20 | 3.12 | +5.05% |
| 24-05-17 | 2.97 | +2.41% |
Real-time BOERSE MUENCHEN
Last update May 23, 2024 at 03:09 am
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Goldman Sachs |
| WKN | GG4MZK |
| ISIN | DE000GG4MZK8 |
| Date issued | 2024-03-01 |
| Strike | 111.7 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.4 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.12 € |
|---|---|
| Lowest since issue | 1.44 € |
| Spread | 0.05 € |
| Spread % | 1.74% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
141.9
USD
Average target price
146.8
USD
Spread / Average Target
+3.48%
- Stock Market
- Certificates
- Certificat
